GM Advisory Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,300
Closed -$87K 209
2022
Q1
$87K Sell
12,300
-9,850
-44% -$81.5K 0.01% 182
2021
Q4
$403K Sell
22,150
-30,765
-58% -$664K 0.04% 144
2021
Q3
$1.03M Buy
52,915
+4,450
+9% +$169K 0.1% 95
2021
Q2
$2.17M Buy
48,465
+25,745
+113% +$1.19M 0.22% 59
2021
Q1
$1.14M Buy
+22,720
New +$1.55M 0.14% 76

Other funds holding CELL

GM Advisory Group's CELL Position: Q2 2022 in Review

GM Advisory Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 12,300 shares — an estimated $87K sold.

GM Advisory Group first reported a position in CELL in Q1 2021 and held it in 5 quarters. The position peaked at $2.17M in Q2 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • GM Advisory Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • GM Advisory Group sold 12,300 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $87K.
  • GM Advisory Group first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • GM Advisory Group's PhenomeX Inc. Common Stock position peaked at $2.17M in Q2 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on GM Advisory Group's 13F filing for Q2 2022, filed 15 Aug 2022.